Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OPRM1 | P35372 | 3/20 | 0.52 |
| ▸ | OPRD1 | P41143 | 3/20 | 0.52 |
| ▸ | CASP3 | P42574 | 2/20 | 0.51 |
| ▸ | CASP7 | P55210 | 1/20 | 0.51 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.49 |
| ▸ | KISS1R | Q969F8 | 3/20 | 0.48 |
| ▸ | BACE1 | P56817 | 1/20 | 0.47 |
| ▸ | BACE2 | Q9Y5Z0 | 1/20 | 0.47 |
| ▸ | CASP1 | P29466 | 1/20 | 0.46 |
| ▸ | CASP9 | P55211 | 1/20 | 0.46 |
| ▸ | ENPEP | Q07075 | 3/20 | 0.45 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31366752 | 0.95 | OPRM1 (0.55) | OPRM1OPRD1CASP3CASP7OPRK1 | |
| SCHEMBL38662319 | 0.93 | OPRD1 (0.53) | OPRM1OPRD1CASP3CASP7OPRK1 | |
| SCHEMBL31134971 | 0.93 | MME (0.47) | OPRM1OPRD1OPRK1BACE1BACE2 | |
| SCHEMBL31257978 | 0.92 | OPRD1 (0.57) | OPRM1OPRD1OPRK1KISS1RSLC6A2 | |
| SCHEMBL29702198 | 0.90 | OPRM1 (0.52) | OPRM1OPRD1OPRK1KISS1R | |
| SCHEMBL30055181 | 0.90 | MME (0.49) | OPRM1OPRD1OPRK1BACE1 | |
| SCHEMBL29960300 | 0.89 | OPRD1 (0.52) | OPRM1OPRD1CASP3CASP7OPRK1 | |
| SCHEMBL29860725 | 0.88 | OPRM1 (0.53) | OPRM1OPRD1CASP3CASP7OPRK1 | |
| SCHEMBL29993688 | 0.87 | NAALAD2 (0.49) | OPRM1OPRD1CASP3OPRK1KISS1R | |
| SCHEMBL29860442 | 0.87 | OPRD1 (0.59) | OPRM1OPRD1OPRK1KISS1RBACE1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4701649-A1 | TREATMENT OF DIABETES MELLITUS | Carmot Therapeutics Inc. (US) | 2026-03-04 | — | — | EP | disclosed |
| WO-2024226540-A1 | TREATMENT OF DIABETES MELLITUS | CARMOT THERAPEUTICS INC. (US) | 2024-10-31 | — | — | WO | disclosed |